Goldman Sachs updated its price target on AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN) shares to GBP150.67, down from GBP155.58, while reaffirming a Buy rating on the stock. The adjustment follows a ...
Introduction Biosimulation technology is a computational approach that uses advanced software and algorithms to simulate biological systems, pr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback